<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>100 years ago, hematopoietic stem cells were postulated as blood lymphocyte-like cells </plain></SENT>
<SENT sid="1" pm="."><plain>Within the last 20 years, the frequency of autologous and allogeneic transplantation of hematopoietic stem cells has increased </plain></SENT>
<SENT sid="2" pm="."><plain>Hematopoietic growth factors allow the stem cells' mobilization from the bone marrow into the peripheral blood </plain></SENT>
<SENT sid="3" pm="."><plain>Quantification of these hematopoietic stem cells by means of flow cytometry can be achieved within hours </plain></SENT>
<SENT sid="4" pm="."><plain>A minimum quantity of 2.0 x 10(6) CD34-positive blood stem cells per kg body weight allows hematopoietic reconstitution within 14 days after infusion of the transplant </plain></SENT>
<SENT sid="5" pm="."><plain>High-dose therapy followed by the transplantation of autologous blood stem cell transplantation is an established therapy for relapsed high-grade <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Especially in cases of subgroups of <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo>, <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> and myeloproliferative syndromes, myeloablative high-dose therapy followed by the transplantation of allogeneic stem cells leads to a better prognosis </plain></SENT>
<SENT sid="7" pm="."><plain>Reduced conditioning before an allogeneic transplantation decreases early <z:mp ids='MP_0010769'>lethality</z:mp> </plain></SENT>
<SENT sid="8" pm="."><plain>The combination of myeloablative high dose therapy followed by autologous hematopoietic stem cell transplantation and allogeneic stem cell transplantation will lead to maximum <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> reduction and development of a graft-versus-<z:hpo ids='HP_0001909'>leukemia</z:hpo> reaction with reduced toxicity </plain></SENT>
<SENT sid="9" pm="."><plain>Hematopoietic stem cell transplantation is to be carried out in studies </plain></SENT>
</text></document>